Developmental plasticity of murine and human Foxp3+ Regulatory T cells

Advances in Immunology

Volumn 119, Issue , 2013, Pages 85-106

  Liston, Adrian ^a   Piccirillo, Ciriaco A ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Differentiation; Epigenetics; Foxp3; Infection; Plasticity; Tolerance; Treg

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL FATE; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELLULAR IMMUNITY; DISEASE COURSE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOREGULATION; INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE;

EID: 84880418854     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407707-2.00003-5     Document Type: Chapter

References (78)

1. Abbas A.K., Benoist C., Bluestone J.A., Campbell D.J., Ghosh S., Hori S., et al. Regulatory T cells: Recommendations to simplify the nomenclature. Nature Immunology 2013, 14(4):307-308.
2. Antov A., Yang L., Vig M., Baltimore D., Van Parijs L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. Journal of Immunology 2003, 171(7):3435-3441.
3. Appel H., Wu P., Scheer R., Kedor C., Sawitzki B., Thiel A., et al. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis. Journal of Rheumatology 2011, 38(11):2445-2451.
4. Atanackovic D., Cao Y., Kim J.W., Brandl S., Thom I., Faltz C., et al. The local cytokine and chemokine milieu within malignant effusions. Tumour Biology 2008, 29(2):93-104.
5. Baron U., Floess S., Wieczorek G., Baumann K., Grutzkau A., Dong J., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. European Journal of Immunology 2007, 37(9):2378-2389.
6. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 2001, 27(1):20-21.
7. Berretta F., St-Pierre J., Piccirillo C.A., Stevenson M.M. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Journal of Immunology 2011, 186(8):4862-4871.
8. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441(7090):235-238.
9. Beyer M., Thabet Y., Muller R.U., Sadlon T., Classen S., Lahl K., et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nature Immunology 2011, 12(9):898-907.
10. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001, 27(1):68-73.
11. Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., et al. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scandinavian Journal of Immunology 2006, 63(6):444-452.
12. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of Experimental Medicine 2003, 198(12):1875-1886.
13. Conroy H., Galvin K.C., Higgins S.C., Mills K.H. Gene silencing of TGF-beta1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells. Cancer Immunology, Immunotherapy 2012, 61(3):425-431.
14. de Kleer I., Vercoulen Y., Klein M., Meerding J., Albani S., van der Zee R., et al. CD30 discriminates heat shock protein 60-induced FOXP3+ CD4+ T cells with a regulatory phenotype. Journal of Immunology 2010, 185(4):2071-2079.
15. de Kleer I.M., Wedderburn L.R., Taams L.S., Patel A., Varsani H., Klein M., et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. Journal of Immunology 2004, 172(10):6435-6443.
16. Deknuydt F., Bioley G., Valmori D., Ayyoub M. IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clinical Immunology 2009, 131(2):298-307.
17. d'Hennezel E., Ben-Shoshan M., Ochs H.D., Torgerson T.R., Russell L.J., Lejtenyi C., et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. New England Journal of Medicine 2009, 361(17):1710-1713.
18. d'Hennezel E., Yurchenko E., Sgouroudis E., Hay V., Piccirillo C.A. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells. Journal of Immunology 2011, 186(12):6788-6797.
19. Duarte J.H., Zelenay S., Bergman M.L., Martins A.C., Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. European Journal of Immunology 2009, 39(4):948-955.
20. Ehrchen J.M., Sunderkotter C., Foell D., Vogl T., Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 2009, 86(3):557-566.
21. Feuerer M., Hill J.A., Mathis D., Benoist C. Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes. Nature Immunology 2009, 10(7):689-695.
22. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biology 2007, 5(2):e38.
23. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 2003, 4(4):330-336.
24. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunology 2005, 6(11):1142-1151.
25. Franceschini D., Paroli M., Francavilla V., Videtta M., Morrone S., Labbadia G., et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. Journal of Clinical Investigation 2009, 119(3):551-564.
26. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445(7129):771-775.
27. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(17):6659-6664.
28. Golding A., Rosen A., Petri M., Akhter E., Andrade F. Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: Implications for antiviral and autoimmune responses. Immunology 2010, 131(1):107-117.
29. Grinberg-Bleyer Y., Saadoun D., Baeyens A., Billiard F., Goldstein J.D., Gregoire S., et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. Journal of Clinical Investigation 2010, 120(12):4558-4568.
30. Hackl D., Loschko J., Sparwasser T., Reindl W., Krug A.B. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs. European Journal of Immunology 2011, 41(5):1334-1343.
31. Han G.M., O'Neil-Andersen N.J., Zurier R.B., Lawrence D.A. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cellular Immunology 2008, 253(1-2):92-101.
32. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061.
33. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004, 21(2):267-277.
34. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nature Immunology 2006, 7(4):401-410.
35. Jarnicki A.G., Lysaght J., Todryk S., Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. Journal of Immunology 2006, 177(2):896-904.
36. Jia T., Fu H., Sun J., Zhang Y., Yang W., Li Y. Foxp3 expression in A549 cells is regulated by Toll-like receptor 4 through nuclear factor-kappaB. Molecular Medicine Reports 2012, 6(1):167-172.
37. Jiao Z., Wang W., Jia R., Li J., You H., Chen L., et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scandinavian Journal of Rheumatology 2007, 36(6):428-433.
38. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunology 2003, 4(4):337-342.
39. Koenen H.J., Smeets R.L., Vink P.M., van Rijssen E., Boots A.M., Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112(6):2340-2352.
40. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., Hori S. Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(6):1903-1908.
41. Lal G., Zhang N., van der Touw W., Ding Y., Ju W., Bottinger E.P., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. Journal of Immunology 2009, 182(1):259-273.
42. Lathrop S.K., Bloom S.M., Rao S.M., Nutsch K., Lio C.W., Santacruz N., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478(7368):250-254.
43. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. The Journal of Experimental Medicine 2008, 205(9):1993-2004.
44. Liu H., Komai-Koma M., Xu D., Liew F.Y. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(18):7048-7053.
45. Liyanage U.K., Goedegebuure P.S., Moore T.T., Viehl C.T., Moo-Young T.A., Larson J.W., et al. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. Journal of Immunotherapy 2006, 29(4):416-424.
46. Loser K., Vogl T., Voskort M., Lueken A., Kupas V., Nacken W., et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nature Medicine 2010, 16(6):713-717.
47. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142(6):914-929.
48. Manfredi A.A., Capobianco A., Bianchi M.E., Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Critical Reviews in Immunology 2009, 29(1):69-86.
49. Marie J.C., Letterio J.J., Gavin M., Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. The Journal of Experimental Medicine 2005, 201(7):1061-1067.
50. Milkova L., Voelcker V., Forstreuter I., Sack U., Anderegg U., Simon J.C., et al. The NF-kappaB signalling pathway is involved in the LPS/IL-2-induced upregulation of FoxP3 expression in human CD4+CD25high regulatory T cells. Experimental Dermatology 2010, 19(1):29-37.
51. Miyao T., Floess S., Setoguchi R., Luche H., Fehling H.J., Waldmann H., et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012, 36(2):262-275.
52. Moo-Young T.A., Larson J.W., Belt B.A., Tan M.C., Hawkins W.G., Eberlein T.J., et al. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. Journal of Immunotherapy 2009, 32(1):12-21.
53. Mottonen M., Heikkinen J., Mustonen L., Isomaki P., Luukkainen R., Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clinical and Experimental Immunology 2005, 140(2):360-367.
54. Nistala K., Moncrieffe H., Newton K.R., Varsani H., Hunter P., Wedderburn L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis and Rheumatism 2008, 58(3):875-887.
55. Nyirenda M.H., Sanvito L., Darlington P.J., O'Brien K., Zhang G.X., Constantinescu C.S., et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. Journal of Immunology 2011, 187(5):2278-2290.
56. Oldenhove G., Bouladoux N., Wohlfert E.A., Hall J.A., Chou D., Dos Santos L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31(5):772-786.
57. Piccirillo C.A., d'Hennezel E., Sgouroudis E., Yurchenko E. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: In vivo veritas. Current Opinion in Immunology 2008, 20(6):655-662.
58. Polansky J.K., Kretschmer K., Freyer J., Floess S., Garbe A., Baron U., et al. DNA methylation controls Foxp3 gene expression. European Journal of Immunology 2008, 38(6):1654-1663.
59. Raffin C., Raimbaud I., Valmori D., Ayyoub M. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells. Journal of Immunology 2011, 187(10):5196-5202.
60. Rubartelli A., Lotze M.T. Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology 2007, 28(10):429-436.
61. Rubtsov Y.P., Niec R.E., Josefowicz S., Li L., Darce J., Mathis D., et al. Stability of the regulatory T cell lineage in vivo. Science 2010, 329(5999):1667-1671.
62. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004, 22:531-562.
63. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995, 155(3):1151-1164.
64. Schlenner S.M., Weigmann B., Ruan Q., Chen Y., von Boehmer H. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. The Journal of Experimental Medicine 2012, 209(9):1529-1535.
65. Sharma M.D., Hou D.Y., Baban B., Koni P.A., He Y., Chandler P.R., et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 2010, 33(6):942-954.
66. Sieper J. Disease mechanisms in reactive arthritis. Current Rheumatology Reports 2004, 6(2):110-116.
67. Tai X., Cowan M., Feigenbaum L., Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nature Immunology 2005, 6(2):152-162.
68. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. Journal of Clinical Investigation 2003, 112(9):1437-1443.
69. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445(7129):766-770.
70. Wiesen J.L., Tomasi T.B. Dicer is regulated by cellular stresses and interferons. Molecular Immunology 2009, 46(6):1222-1228.
71. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunology 2007, 8(3):277-284.
72. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. International Immunology 2004, 16(11):1643-1656.
73. Yan B., Ye S., Chen G., Kuang M., Shen N., Chen S. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis and Rheumatism 2008, 58(3):801-812.
74. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29(1):44-56.
75. Zhang Y., Luo F., Cai Y., Liu N., Wang L., Xu D., et al. TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. Journal of Immunology 2011, 186(4):1963-1969.
76. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463(7282):808-812.
77. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445(7130):936-940.
78. Zhu X.M., Yao Y.M., Liang H.P., Xu C.T., Dong N., Yu Y., et al. High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4. Cytokine 2011, 54(3):296-304.